Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer Clinical Trial

Official title:
Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer

Status Recruiting

Clinical Trial Summary

Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin in the First -line treatment of advanced primary liver cancer

Clinical Trial Description

Patients with advanced primary liver cancer will be enrolled in the trial , then separated randomly into two group. One group treated with the Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin , another group treated with Systematic Chemotherapy including Oxaliplatin. The purpose of the study is to evaluate the effect and safety of the Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin in the First -line treatment of advanced primary liver cancer ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03166553
Study type	Interventional
Source	BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
Contact	Shukui Qin
Phone	025-80864541
Email	qinsk@csco.org.cn
Status	Recruiting
Phase	N/A
Start date	November 28, 2016
Completion date	November 27, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03167775` - Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer	N/A
Not yet recruiting	`NCT05411757` - IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer	Early Phase 1
Completed	`NCT03092895` - A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC	Phase 2